blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4061848

EP4061848 - ANTI-ROR-2 ANTIBODIES AND METHODS OF USE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.08.2022
Database last updated on 28.09.2024
FormerThe international publication has been made
Status updated on  29.05.2021
Most recent event   Tooltip11.09.2024The date on which the examining division becomes responsible, has been established 
11.09.2024Amendment by applicant 
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street
Twelfth Floor
Oakland, CA 94607 / US
[2022/39]
Inventor(s)01 / KIPPS, Thomas J.
13175 Caminito Mendiola
San Diego, California 92130 / US
02 / WIDHOPF, George F., II
5911 Seacrest View Road
San Diego, California 92121 / US
 [2022/39]
Representative(s)Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
[N/P]
Former [2022/39]Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstraße 2
81541 München / DE
Application number, filing date20889747.018.11.2020
[2022/39]
WO2020US61130
Priority number, dateUS201962936900P18.11.2019         Original published format: US 201962936900 P
[2022/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021102055
Date:27.05.2021
Language:EN
[2021/21]
Type: A1 Application with search report 
No.:EP4061848
Date:28.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2021 takes the place of the publication of the European patent application.
[2022/39]
Search report(s)International search report - published on:US27.05.2021
(Supplementary) European search report - dispatched on:EP20.02.2024
ClassificationIPC:C07K16/28, C07K16/30, C07K19/00, A61P35/00
[2022/39]
CPC:
C07K16/2803 (EP,IL,KR,US); A61K39/4611 (EP,IL,KR); A61K39/4613 (EP,IL,KR);
A61K39/4631 (EP,IL,KR); A61K39/464411 (EP,IL,KR); A61K47/6849 (US);
A61P35/00 (EP,IL,KR,US); C07K14/7051 (EP,IL,US); G01N33/57484 (KR);
G01N33/57492 (US); A61K2039/505 (KR); A61K2239/50 (EP,IL,KR);
A61K38/00 (US); C07K2317/24 (US); C07K2317/33 (EP,IL,KR);
C07K2317/34 (EP,IL,KR,US); C07K2317/524 (US); C07K2317/526 (US);
C07K2317/565 (US); C07K2317/622 (EP,IL,US); C07K2317/77 (EP,IL,KR,US);
C07K2317/92 (EP,IL,KR,US); C07K2319/02 (US); C07K2319/03 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/39]
TitleGerman:ANTI-ROR-2-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG[2022/39]
English:ANTI-ROR-2 ANTIBODIES AND METHODS OF USE[2022/39]
French:ANTICORPS ANTI-ROR-2 ET MÉTHODES D'UTILISATION[2022/39]
Entry into regional phase15.06.2022National basic fee paid 
15.06.2022Search fee paid 
15.06.2022Designation fee(s) paid 
15.06.2022Examination fee paid 
Examination procedure15.06.2022Examination requested  [2022/39]
11.09.2024Amendment by applicant (claims and/or description)
11.09.2024Date on which the examining division has become responsible
Fees paidRenewal fee
28.11.2022Renewal fee patent year 03
27.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2019016392  (NBE THERAPEUTICS AG [CH]) [X] 1,13-15 * Page 1, paragraph 1, page 2, paragraph 2, last paragraph of page 32 - page 33 Pages 57, 58 *[I] 2-12
International search[A]WO2008031009  (GENENTECH INC [US], et al) [A] 1* pg 19 para 4 - pg 20 para 1, pg 20 para 2, SEQ ID NO: 17 *;
 [A]WO2016166297  (VAN BERKEL PATRICIUS HENDRIKUS CORNELIS [CH], et al) [A] 1-10, 12-13, 73, 77, 81-84 * Claim 130, SEQ ID NO: 1 *;
 [A]WO2017197234  (BIOATLA LLC [US]) [A] 1-10, 12-13, 73, 77, 81- 84 * para [0064]-[0065], [0073],[0088], [0252], [0258], [0261], [0291], Abstract *;
 [A]WO2017218707  (XENCOR INC [US]) [A] 1-10, 12-13, 73, 77, 81-84 * para [00171], SEQ ID NO: 9826 *;
 [A]US2019031754  (RADER CHRISTOPH [US], et al) [A] 77, 81-84 * para [0010], [0019]-[0020], [0042], [0067], [0106], Abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.